Close

Articles Posted in Bard Avaulta

Updated:

AMS-Endo Announces Vaginal Mesh lawsuit final settlement

AMS-Endo announces Vaginal Mesh lawsuit final settlement, as reported by Bloomberg News. Endo Pharmaceuticals, the owner of American Medical System (AMS) agreed to another $775 million to settle vaginal mesh injury lawsuits. Endo has paid more than $2.6 billion to settle “virtually all known” vaginal injury claims. More than 100,000…

Updated:

Ethicon Vaginal Mesh $20 Million Verdict

Ethicon Vaginal mesh lawsuit ends in plaintiff’s verdict. The jury in a Philadelphia state court jury found for a plaintiff and awarded a $20 million verdict against Johnson & Johnson’s Ethicon division, over complications with the Ethicon TVT-Secur transvaginal mesh. Philadelphia Ethicon Vaginal Mesh Trial Margaret Engleman, brought a lawsuit…

Updated:

Vaginal Mesh Side Effects Lawsuits

Vaginal mesh side effects continue to plague the blockbuster plastic medical devices with severe and catastrophic complications. But just don’t take my word for it, according to court documents, Vaginal Mesh Injury lawsuit claims continue to be filed nationwide and have been so for the past 7 years. Over 100,000 Vaginal…

Updated:

Bard Avaulta TransVaginal Mesh Settlement in the Works

After a hard fought, protracted and bitter fight that has consumed the last 5 years, the Bard Avaulta transvaginal mesh litigation is finally heading for a global settlement. U.S. District Judge, John Goodwin, who presiding over all federal vaginal mesh lawsuits has appointed a Special Master to forge settlement talks…

Updated:

FDA: Reclassification of Trans Vaginal Mesh as High Risk Device

The U.S. Food and Drug Administration today issued two proposed orders to address the health risks associated with surgical mesh used for transvaginal repair of pelvic organ prolapse (POP). If finalized, the orders would reclassify surgical mesh for transvaginal POP from a moderate-risk device (class II) to a high-risk device…

Updated:

Bard, Boston Scientific, Endo Health/AMS Vaginal-Mesh Makers Settlement on the horizon

As a Texas Vaginal Mesh attorney, and Dallas medical doctor, we are reporting this important potential transvaginal mesh settlement breakthrough. According to sources, C.R. Bard Inc., and other makers of vaginal-mesh implants, are in advanced talks to settle thousands of vaginal mesh product liability lawsuits. Bard, Endo Health Solutions Inc.…

Updated:

Bard, Ethicon, Boston Scientific, AMS, Coloplast Vaginal Mesh Litigation

Transvaginal mesh injury lawsuits are consolidated and coordinated in 6 individual multidistrict litigations (MDLs) established in the federal court system. These injury claims against vaginal mesh manufacturers have now become the largest pending litigation in the U.S. 30,000 Active Mesh Lawsuits and Climbing There are more than 30,000 complaints filed…

Updated:

Bard Avaulta Mesh Cases Beginning to Settle

According to reports, C.R. Bard Inc., has agreed to settle a one of its Avaulta vaginal-mesh implant lawsuits, which allegedly caused severe urinary problems. This case was set for  trial this month in New Jersey. Bard agreed to pay an undisclosed sum to resolve Melanie Virgil’s claims that Bard’s Avaulta…

Updated:

Boston Scientific Pelvic Mesh Selected for Bellwether Trials

The U.S. District Judge presiding over the federal transvaginal mesh litigation has chosen four Boston Scientific cases that will be considered for early bellwether trials, scheduled to start in 2014. Litigation Continues to Grow There are more than 22,500 federal lawsuits involving vaginal mesh pelvic repair systems manufactured by different…

Updated:

Bard Settles 2nd Avaulta Transvaginal Mesh Lawsuit

Recently, Bard settled the second federal Avaulta bellwether trial over its alleged defective transvaginal mesh devices. The settlement was announced by U.S. District Judge Goodwin, who is supervising the transvaginal mesh product liability lawsuits in Charleston, W.Va. As previously noted, in the first Bard Avaulta bellwether trial, the jury awarded…

Contact Us
Start Chat